A New drug for Arthritis and Lupus
Lupus is characterized by tissue damage and inflammation. This autoimmune disorder is caused by the body’s immune system attacking its own tissues and cells. Rheumatoid Arthritis is also characterized by tissue damage and inflammation, but the cause is unknown. Both conditions are being studied in the hopes of designing new treatments that are more effective than the currently used treatments, methotrexate and anti-CD3.
The following article gives information about a new drug that has been tested on mice in Australia. The drug has shown promising results as being an effective treatment for lupus and arthritis in the mice, and researchers are hoping it will show the same results when tested on humans. This article also discusses how the scientists honed in on a human receptor – FcgammaRIIA – and used mice that carried this receptor for their studies of the new drug.
This article gives information on the drug, how the scientists created molecules, and how the new drug works. The article concludes that the new drug represses both diseases longer the currently used drugs.
New inhibitor drug seen for rhuematoid arthritis, lupus
Return to the Social Security Disability SSI Benefits Blog
How much is the average Social security Disability payment?
When should you file for Disability Benefits
Appealing a Denied Disability Claim
Rheumatoid Arthritis Social Security Disability SSI - Applying for Disability